For U.S. Consumers

Important Safety Information | Prescribing Information

Lastacaft

Works fast at 3 minutes and lasts all day through 16 hours to prevent itching due to eye allergies1

Save instantly on LASTCAFT® Ask your eye doctor Doctor icon Explore icon
Save now About lastacaft Your itchy eyes Your itchy eyes
About|About|About|About
Do you have itchy allergy eyes?

Common causes of itching due to eye allergies include2:

hero allergens


Understanding Allergens That Cause Itchy Allergy Eyes

Allergens are what trigger your eye allergies. To the body, allergens are considered foreign substances that threaten or irritate the body, such as pollen from ragweed or cat dander.6,7 If you react to certain allergens, this means your eyes have become sensitized at some point.8 Therefore, when your eyes come into contact with specific allergens, an allergic response results.6-9

How Common Is It?

About 20% of people have eye allergies.3 For those who do, itchy eyes is a very common symptom.4

700_text_88 700_text_88
overlay
overlay
footer

Enter your email address and click the unsubscribe button to remove yourself from our registration list.

We're sorry to see you go.


This field is required.



footer

You have been removed from our registration list and will no longer receive communications from Allergan about LASTACAFT® ophthalmic solution.



footer
overlay
overlay

Coupon Full Terms and Conditions

You must present this coupon to the pharmacist along with your prescription to participate in this program. This coupon is good for up to $10 off the prescription price of LASTACAFT® (alcaftadine ophthalmic solution) 0.25%. In addition, you can save up to an extra $5 if you fill your prescription within 7 days of receiving it from your doctor. This coupon must be presented at the time of fill for instant savings.

For any questions, call the LASTACAFT® Savings Program at 1-855-276-2951.

Eligibility: Offer not valid for people participating in Medicare, Medicaid, or any similar federal or state healthcare program, including any state medical or pharmaceutical assistance programs. If you are eligible for drug benefits under any such program, you cannot use this coupon. Offer void where prohibited by law, taxed, or restricted. This promotion cannot be combined with any other programs, offers, or discounts. Offer good only in the United States. Allergan, Inc., reserves the right to rescind, revoke, and amend this offer without notice.

Offer expires December 31, 2013. Good for one-time use only.

APPROVED USE
LASTACAFT® is a prescription medicine approved for the prevention of itching associated with eye allergies.

IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
To minimize contaminating the dropper tip of the bottle and solution, do not touch your eyelids or the areas around your eyes with the dropper tip. Keep bottle tightly closed when not in use.

Do not wear a contact lens if your eye is red.

LASTACAFT® should not be used to treat contact lens-related irritation.

Remove contact lenses before putting LASTACAFT® in your eyes. The preservative in LASTACAFT® may be absorbed by soft contact lenses. Lenses may be put back in your eyes 10 minutes after using LASTACAFT®.

LASTACAFT® is for topical use in your eyes only.

SIDE EFFECTS
The most common eye-related side effects that were reported in less than 4% of LASTACAFT® treated eyes were: eye irritation, burning and/or stinging in the eyes after use, eye redness, and eye itching.

The most common non–eye-related side effects that were reported in less than 3% of patients with LASTACAFT® treated eyes were: inflammation of the nose and the upper part of the throat, headache, and the flu. Some of these side effects were similar to the symptoms of eye allergies.

Please click here for the full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1080.

footer
overlay
overlay



You will receive an email with a mail-in rebate form shortly.

footer
overlay
overlay


Logo

An email with a link to this website has been sent to:


footer

APPROVED USE
LASTACAFT® is a prescription medicine approved for the prevention of itching associated with eye allergies.

IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
To minimize contaminating the dropper tip of the bottle and solution, do not touch your eyelids or the areas around your eyes with the dropper tip. Keep bottle tightly closed when not in use.

Do not wear a contact lens if your eye is red.

LASTACAFT® should not be used to treat contact lens-related irritation.

Remove contact lenses before putting LASTACAFT® in your eyes. The preservative in LASTACAFT® may be absorbed by soft contact lenses. Lenses may be put back in your eyes 10 minutes after using LASTACAFT®.

LASTACAFT® is for topical use in your eyes only.

SIDE EFFECTS
The most common eye-related side effects that were reported in less than 4% of LASTACAFT® treated eyes were: eye irritation, burning and/or stinging in the eyes after use, eye redness, and eye itching.

The most common non–eye-related side effects that were reported in less than 3% of patients with LASTACAFT® treated eyes were: inflammation of the nose and the upper part of the throat, headache, and the flu. Some of these side effects were similar to the symptoms of eye allergies.

Please click here for the full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1080.

References:

1. LASTACAFT® Prescribing Information. 2. Conjunctivitis (pink eye). Centers for Disease Control and Prevention website. http://www.cdc.gov/conjunctivitis/clinical.html. Updated June 4, 2010. Accessed January 16, 2012. 3. Ono SJ, Lane K. Comparison of effects of alcaftadine and olopatadine on conjunctival epithelium and eosinophil recruitment in a murine model of allergic conjunctivitis. Drug Des Devel Ther. 2011;5:77-84. 4. Bielory L. Ocular allergy. Mt Sinai J Med. 2011;78(5):740-758. 5. Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol. 2000;106(6):1019-1032. 6. Allergen. US National Library of Medicine and National Institutes of Health. MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/002229.htm. Updated February 17, 2011. Accessed January 16, 2012. 7. Allergic conjunctivitis. US National Library of Medicine and National Institutes of Health. MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/001031.htm. Updated August 11, 2010. Accessed January 16, 2012. 8. Allergic reactions. US National Library of Medicine and National Institutes of Health. MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/000005.htm. Updated May 2, 2010. Accessed January 16, 2012. 9. Allergies. US National Library of Medicine and National Institutes of Health. MedlinePlus website. http://www.nlm.nih.gov/medlineplus/ency/article/000812.htm. Updated October 1, 2011. Accessed January 16, 2012.

Privacy & Terms    Allergan.com    Site Map    Unsubscribe

©2013 Allergan, Inc., Irvine, CA 92612  ® marks owned by Allergan, Inc.
Adobe and Reader are registered trademarks owned by Adobe Systems Incorporated.
pskw is a trademark owned by PSKW, LLC.  APC81RE12  123240

The information on this site is intended for U.S. residents only. Please visit the Allergan website for your country of residence for information concerning Allergan products and services available there.

DOWNLOAD BROCHURE  |  REGISTER FOR UPDATES  |  TELL A FRIEND  |  CONTACT US